On May 28, 2026, Staar Surgical Co STAA shares fell 7.3% to a current price of $29.08. This decline comes amidst a volatile trading period, as the stock has experienced a 52-week range of $15.59 to $35.87.
- GF Valueâ„¢ estimates the fair value at $30.94, indicating the stock is currently 6.0% undervalued.
- With a GF Scoreâ„¢ of 81/100, Staar Surgical Co is categorized as a strong investment opportunity.
- Insiders have actively purchased $12.3 million worth of shares in the last three months, signaling confidence in the company's future.
Is STAA Overvalued or Undervalued?
Staar Surgical Co's current price of $29.08 sits below its GF Valueâ„¢ of $30.94, reflecting a 6.0% margin of safety for potential investors. This undervaluation suggests that the stock holds an opportunity for appreciation, given that its current market price does not fully reflect its estimated intrinsic value. However, it's crucial to consider that while the GF Valuation label categorizes the stock as fairly valued, the current dip in price might indicate short-term volatility that could affect investor sentiment.
GF Valueâ„¢ is GuruFocus' proprietary measure of intrinsic value, calculated from historical trading multiples, past business growth, and future performance estimates. Therefore, the current undervaluation may present a buying opportunity, but investors should remain cautious and consider broader market conditions and company fundamentals before making decisions.
How Does STAA's Valuation Compare to Its History?
| Metric | Current | Historical |
|---|---|---|
| P/E (TTM) | 82.2x | 105.2x |
Staar Surgical Co's current forward P/E ratio of 82.2x is significantly below its 5-year median P/E of 105.2x, indicating that the stock is trading at a lower valuation compared to its historical averages. This analysis aligns with the GF Valueâ„¢ verdict of being undervalued, suggesting that the stock may be a compelling prospect for long-term investors seeking growth in the medical devices sector.
What Does STAA's GF Scoreâ„¢ Tell Us?
| Metric | Rating |
|---|---|
| GF Scoreâ„¢ | 81/100 |
| Financial Strength | 7/10 |
| Profitability | 6/10 |
| Growth | 6/10 |
| Valuation | 9/10 |
| Momentum | 10/10 |
The GF Scoreâ„¢ of 81/100 indicates a strong overall performance, highlighting the company's solid financial strength (7/10) and exceptional momentum (10/10) as its strongest areas. However, the profitability and growth ranks (6/10) suggest there is room for improvement in these aspects. The valuation rank of 9/10 further emphasizes the stock's attractive pricing relative to its intrinsic value, reinforcing the potential upside for investors.
What Are Insiders Doing with STAA Stock?
Recent insider activity at Staar Surgical Co has shown significant purchasing, with insiders acquiring $12.3 million in shares over the last three months and no recorded selling. This trend indicates a strong belief among insiders regarding the company's growth prospects and long-term value. Such activity often serves as a positive signal to the market, suggesting that those with the most insight into the company's operations are optimistic about its future performance.
What This Means for Investors
Based on the current analysis, Staar Surgical Co is considered undervalued according to the GF Valueâ„¢ framework. With a strong GF Scoreâ„¢ and favorable insider activity, the stock presents a potential opportunity for investors looking to enter the medical devices market at a reasonable price.
For the complete analysis, visit the Staar Surgical Co STAA stock page. You can also explore the GF Valueâ„¢ page for detailed valuation methodology, or use the GuruFocus Stock Screener to find similar opportunities.
Frequently Asked Questions
What is STAA's GF Scoreâ„¢?
Staar Surgical Co has a GF Scoreâ„¢ of 81/100, indicating a strong overall performance and potential for higher long-term returns.
Is STAA overvalued or undervalued?
According to GF Valueâ„¢, Staar Surgical Co is currently undervalued, with a fair value estimate of $30.94 compared to its current price of $29.08.
What is STAA's P/E ratio?
The forward P/E ratio for Staar Surgical Co is 82.2x, which is below its 5-year median P/E of 105.2x, suggesting it is trading at a lower valuation compared to its historical averages.
This stock alert was generated using automated technology and GuruFocus financial data to provide readers with timely and accurate market reporting. This content was reviewed by GuruFocus editorial team prior to publication. Please send any questions or comments about this story to [email protected].
